Related Experiment Video
Updated: Jun 2, 2026
03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Cost burden of chronic rhinosinusitis: a claims-based study
Neil Bhattacharyya1, Richard R Orlandi, Jeff Grebner
1Division of Otolaryngology, Brigham and Women's Hospital, Boston, MA, USA. neiloy@massmed.org
Summary
Chronic rhinosinusitis (CRS) significantly impacts healthcare costs, with many patients needing long-term care. Endoscopic sinus surgery (ESS) reduces ongoing treatment needs but involves substantial upfront costs.
Area of Science:
- Otolaryngology
- Health Economics
- Epidemiology
Background:
- Chronic rhinosinusitis (CRS) is a prevalent condition affecting millions.
- Understanding the economic burden and healthcare utilization associated with CRS is crucial for resource allocation and patient management.
Purpose of the Study:
- To quantify the cost burden and healthcare utilization for patients diagnosed with chronic rhinosinusitis (CRS).
Main Methods:
- A historical cohort study analyzed medical claims data from 2003 to 2008.
- Patients were identified with CRS based on diagnosis codes, CT scans, or endoscopy.
- Prevalence and costs were determined from a payer's perspective.
Main Results:
- Over 4.4 million patients were studied; 5.5% with acute rhinosinusitis (ARS) developed CRS.
- Nearly 28% of CRS patients required ongoing care for up to 24 months.
- Endoscopic sinus surgery (ESS) patients incurred costs of $2449 pre-surgery and $7726 for the procedure and initial care, with significant cost reductions in subsequent years.
Conclusions:
- A substantial number of chronic rhinosinusitis patients require prolonged medical care.
- Endoscopic sinus surgery (ESS) demonstrates a reduction in long-term healthcare consumption for CRS, despite significant initial procedure costs.
Related Concept Videos
01:23Chronic Pharyngitis
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Nose and Nasal Cavity
The nose is composed of an observable exterior segment (external nose) and an internal segment within the skull known as the nasal cavity (internal nose). The external nose, visible on the face, consists of a framework of bone and hyaline cartilage enveloped in skin and muscle and lined with a mucous membrane. This structure is supported by the frontal bone, nasal bones, and maxillary bone and is supplemented by a cartilaginous framework comprising the septal nasal cartilage, lateral nasal...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:16Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...